"Doctors Are Legally BANNED From Telling You This" - Pharma Whistleblower | Brigham Buhler
Quick Read
Summary
Takeaways
- ❖The US healthcare system is built to monetize and profit from chronic disease, not prevent it.
- ❖Insurance companies control healthcare by dictating covered drugs, tests, and procedures, often prioritizing quarterly profits over patient health.
- ❖Pharmacy Benefit Managers (PBMs), now largely owned by major insurance companies, negotiate *up* drug prices to maximize rebates, which become profit centers.
- ❖Doctors in the traditional system have an average of six minutes per patient, leading to quick prescription of drugs rather than deep diagnostic workups.
- ❖Pharmaceutical companies influence medical education and promote off-label drug use, often for conditions with minimal efficacy differences from placebo.
- ❖The FDA's 510K approval process allows medical devices to enter the market without human safety studies, leading to unreported patient deaths and injuries.
- ❖Non-patentable treatments like peptides and stem cells are suppressed or banned by regulatory bodies, often due to lobbying from pharmaceutical companies that cannot profit from them.
- ❖The average American is on four or more prescription drugs, a direct result of the system's design.
- ❖90% of FDA commissioners have gone to work for the very industries they were supposed to regulate, creating a revolving door of influence.
- ❖Cash-pay medical practices offer comprehensive diagnostics (blood work, DEXA, V2 max) and personalized care, bypassing insurance restrictions and focusing on root causes.
Insights
1Systemic Shift from Patient Care to Profit Generation
The US healthcare system, once characterized by doctors knowing entire families, shifted dramatically when insurance companies took over. This led to primary care physicians being forced to see 40+ patients a day with only six minutes per patient, making preventative care impossible and incentivizing quick prescription of drugs. The system is designed to monetize chronic disease rather than prevent it.
Clinicians went from knowing the family and having 100 patients to seeing 40+ patients a day with six minutes per patient after insurance companies took over. ()
2Gag Clauses and Inflated Drug Prices by PBMs
Pharmacists are legally prohibited from telling patients that their cash-pay price for a drug might be significantly cheaper than their insurance co-pay. This is due to 'gag clauses' imposed by Pharmacy Benefit Managers (PBMs). PBMs, now largely owned by major insurance companies, actively negotiate *up* drug prices with pharmaceutical companies to secure larger rebates, which then become profit for the PBM/insurance company, not savings for the patient or employer.
A pharmacist is not legally allowed to tell a patient their cash price for a drug (e.g., $2 for Metformin) is cheaper than their insurance co-pay (e.g., $10). PBMs, owned by insurance giants, negotiate higher drug prices with pharma for larger rebates, which they keep. (, )
3Insurance Companies Deny Comprehensive Diagnostics
Insurance companies actively prevent doctors from ordering comprehensive diagnostic tests like full blood panels, DEXA scans, or V2 max tests. They limit what is covered to minimal panels, threatening to terminate contracts with clinicians who order more extensive testing. This obstruction prevents early detection and preventative interventions for conditions like pre-diabetes or hormonal imbalances.
Insurance companies send 'nasty letters' to clinicians, threatening to terminate contracts if they continue to pull comprehensive blood work beyond five minimal panels. ()
4Pharmaceutical Influence on Medical Education and Off-Label Promotion
Pharmaceutical companies fund medical education and continuing education for doctors, shaping their understanding of diseases and treatments. Drug reps are tasked with growing patient populations for specific drugs, even subtly promoting off-label uses by citing company-funded 'experts' who discuss such applications, thus increasing prescriptions without direct kickbacks.
Drug reps were given call sheets of biggest prescribers and told to 'become their best friend' to grow patient populations for mental health drugs. Companies funded psychologists/psychiatrists to educate reps on growing markets. (, ) Reps were trained not to promote off-label but then exposed to charismatic neurologists from universities (funded by pharma) discussing off-label uses, planting seeds for doctors. ()
5Flawed FDA Approval and Regulatory Capture
The FDA's 510K approval process allows 92% of surgical products (pacemakers, implants, etc.) to enter the market without human safety studies, relying instead on 'daisy-chaining' to older, dissimilar technologies. This has led to unreported patient deaths and injuries. Furthermore, 60-80% of FDA-approved drugs face major recalls or label changes. A 'revolving door' exists where 90% of FDA commissioners go on to work for the very industries they regulated, highlighting deep regulatory capture.
Less than 10% of surgical products (92% by implication) have human safety studies due to the 510K approval process. () 60-80% of FDA-approved drugs have major recalls or label changes. () 90% of FDA commissioners have gone to work for the industries they regulated. ()
6Suppression of Non-Patentable Preventative Treatments
Treatments like hormone optimization (testosterone, estrogen), peptides, and stem cells are often ignored or actively suppressed by pharmaceutical and insurance companies because they are difficult or impossible to patent. This prevents widespread adoption and coverage, pushing patients towards more expensive, patentable drugs that treat symptoms rather than root causes. The FDA banned 19 peptides overnight without providing safety data, forcing them into a 'gray and black market'.
Testosterone is considered a 'lifestyle drug' and is difficult to get covered by insurance. The dogma around testosterone causing cancer stemmed from a 1930s study of three people and has been debunked. (, ) Peptides are short-chain amino acids found naturally and cannot be patented, making them unattractive for big pharma. () The FDA banned 19 'blockbuster peptides' overnight without responding to 17 FOIA requests for safety data, driving them to unregulated markets. (, )
7Hospital Incentives for Vaccine Schedules
Large hospital systems, which often own pediatric and primary care practices, purchase vaccines in bulk at wholesale prices. They then implement compliance programs that incentivize their pediatricians with bonuses for maintaining high vaccination rates among patients. This creates a revenue stream for the institution and a 'brainwashed' mindset among clinicians who believe they are doing good, even when the necessity of certain vaccines (like Hep B for newborns) is questionable.
Hospital systems buy vaccines in bulk and build compliance programs that incentivize pediatricians for maintaining vaccination schedules, indirectly bonusing them for revenue generation. () The CDC no longer recommends the Hepatitis B vaccine for newborns, yet hospitals continue to push it. ()
Bottom Line
Advanced cellular therapies like 'Muse stem cells' from Japan demonstrate extreme resilience and potential for long-term healing, remaining in the body for years and even shrinking tumors, far surpassing current US-standard stem cell treatments.
This technology could revolutionize treatment for chronic diseases, organ repair, and aging, but current US regulatory hurdles (driven by industry interests) prevent its accessibility, forcing patients to seek treatments offshore or through unregulated channels.
Advocate for regulatory pathways that allow for the safe and accessible use of advanced cellular therapies in the US, potentially creating a new paradigm for regenerative medicine and longevity, democratizing access to cutting-edge treatments.
The 'heterochronic parabiosis' concept (young blood rejuvenating old tissue) is being applied in clinics via 'plasma apheresis,' where old plasma is removed and replaced with fresh albumin and cellular 'goodies' (MSCs, exosomes) to reverse aging and inflammation.
This demonstrates a direct, scientifically backed method for biological rejuvenation, moving beyond theoretical anti-aging to practical, albeit currently expensive and regulated, interventions.
Develop more affordable and accessible plasma apheresis treatments combined with advanced cellular products, potentially creating a new market for systemic rejuvenation and health optimization, especially if regulatory pathways are streamlined for cash-pay models.
Gene activation shots exist (developed by DoD geneticists) that can make bones eight times stronger or significantly increase muscle mass by activating specific genes like follistatin, effectively creating 'X-Men' capabilities.
Human genetic engineering is no longer science fiction but a present reality, with profound implications for human performance, disease resistance, and longevity. These technologies are currently operating offshore due to regulatory restrictions.
Explore ethical and regulatory frameworks for human genetic enhancement and disease prevention, potentially leading to a future where genetic predispositions to illness are 'edited out' and human capabilities are safely augmented, creating entirely new industries in personalized genomic health.
Opportunities
Cash-Pay Preventative Health Clinics (e.g., Ways to Well)
Establish clinics that operate entirely outside the insurance model, offering comprehensive diagnostic workups (blood work, DEXA, V2 max, genetic screening, gut biome tests) and personalized preventative care plans. Focus on identifying root causes of health issues and providing affordable, accessible treatments (including compounded peptides, hormone optimization, and advanced cellular therapies where legally permissible) directly to patients.
Affordable Compounding Pharmacies for Non-Patentable Drugs
Create pharmacies that specialize in compounding medications and peptides that are either too expensive through traditional insurance or are not covered because they are non-patentable. This offers a cheaper, more accessible alternative to patented drugs, directly challenging the PBM/pharma profit model.
AI-Powered Health Data Analysis and Guidance Platform
Develop a large language model (LLM) based app that allows users to upload their diagnostic data (blood work, DEXA, V2 max from any source) for comprehensive analysis. The AI would provide personalized insights, answer health questions, explain root causes, and guide users toward preventative strategies, connecting them with cash-pay pharmacies or clinics as needed.
Key Concepts
The Problem is with the Tank, Not the Fish
This model suggests that when a system (the 'tank') is inherently flawed or corrupted, individual components (the 'fish' or doctors/patients) will inevitably suffer or behave suboptimally. In healthcare, it means individual doctors may mean well, but the overarching profit-driven structure of insurance, pharma, and regulation makes it impossible for them to provide optimal preventative care.
Regulatory Capture
This describes a situation where a regulatory agency, created to act in the public interest, instead advances the commercial or political concerns of special interest groups that dominate the industry or sector it is charged with regulating. Examples include the revolving door between FDA commissioners and pharmaceutical companies, and pharmaceutical lobbying influencing FDA decisions on drug approvals and bans.
Lessons
- Take autonomy over your health: Do not solely rely on the traditional, insurance-driven healthcare system for preventative care, as it is designed to monetize chronic disease.
- Seek comprehensive diagnostics: Opt for cash-pay comprehensive blood work, DEXA scans, and V2 max tests to understand your physiological and biological markers, identifying root causes before symptoms become chronic diseases.
- Question your prescriptions: If a doctor prescribes medication without a deep dive into your health, diet, and lifestyle, seek a second opinion or a cash-pay practice that focuses on root cause analysis.
- Explore non-traditional treatments: Research and consider non-patentable, preventative treatments like hormone optimization and peptides, which may be more effective and affordable outside the insurance model.
- Educate yourself on food systems: Be aware of food additives, glyphosate levels, and processed foods, as they significantly impact metabolic health and chronic disease risk. Prioritize whole, unprocessed foods.
Building Your Personal Health Life Raft
**Step 1: Get Proactive & Predictive Diagnostics.** Invest in comprehensive cash-pay blood work (70+ markers), DEXA scans (body composition, visceral fat), and V2 max tests (cardiovascular health). This 'look under the hood' identifies predispositions and root causes before chronic disease manifests. (06:10, 30:09)
**Step 2: Seek Root Cause-Oriented Clinicians.** Find medical practices, often cash-pay, that dedicate significant time (45+ minutes) to patient consultations, integrate all diagnostic data, and prioritize diet, lifestyle, and hormone optimization over immediate prescription drugs. (20:07, 38:00)
**Step 3: Understand the Financial Incentives.** Recognize that the traditional system (insurance, PBMs, big pharma) profits from your illness. Be prepared to pay cash for preventative care, as it bypasses the system's inherent conflicts of interest and often provides better value and results. (03:55, 44:49)
**Step 4: Embrace Lifestyle as Medicine.** Prioritize diet, exercise, and sleep. Understand that these foundational elements often outperform prescription drugs for mental health and metabolic well-being. Use medications as tools, not primary solutions, and only after comprehensive assessment. (15:16, 15:55)
**Step 5: Advocate for Your Health Choices.** Be informed about your options, including non-patentable treatments like peptides and stem cells. Don't be afraid to question your doctor or fight insurance denials, as less than 10% of patients object, allowing the system to push its will. (22:51, 01:06:20)
Notable Moments
The 'Squeaky Hip' Lawsuit
This anecdote highlights the absurd consequences of the FDA's 510K approval process, where medical devices are cleared without human safety studies. A joint implant that audibly squeaked during activity led to a lawsuit, demonstrating how lack of rigorous testing can result in unexpected and debilitating product failures, even if seemingly humorous.
Liquid Nitrogen in Stem Cells
This chilling example illustrates the dangers of unregulated or improperly handled advanced therapies. Early stem cell companies failed to validate packaging for liquid nitrogen storage, leading to patients being injected with contaminated, freezing liquid, causing paralysis and death. This event created a widespread fear and regulatory backlash against stem cells, despite the product itself not being the issue.
Jelly Roll's Health Transformation
The story of Jelly Roll's weight loss and health improvement, guided by Ways to Well, showcases the effectiveness of a holistic, root-cause approach. By optimizing hormones, reducing inflammation, and focusing on diet and exercise, he achieved significant results without relying on GLP-1s, demonstrating that personal commitment combined with proper biological optimization can lead to profound, sustainable change.
Quotes
"If you use insurance and you go to the average primary care in America and you get the average blood work and you get on the average medication, don't be surprised when you die of the average chronic disease. The system's not built to prevent. It's built to monetize and profit off chronic disease."
"There has never been one single study. There has never been one single autopsy. There has never been the ability to quantify serotonin levels in the brain that statistically show that anti-depressants are working at a chemical level."
"The margins are made in the mystery. It is intentional. It is by design to make it deceptive and confusing. So the burden is on you, the patient, and you get frustrated and you give up."
"92% of the that has gone into the operating room for the last 20 years has never had one single human safety study."
"60 to 80% of the drugs that have been approved by the FDA will have a major recall or label change."
"90% of the commissioners of the FDA have gone to work for the very industries that they're supposed to regulate."
"The difference between a chronically ill, dying human being of diabetes and a healthy human being is less than a teaspoon of sugar in the blood at a time. Do you know how much sugar is in one soft drink? Eight teaspoons."
"If what we were doing for the last 20 years worked, then why are we more sick than ever, more diabetic than ever, more riddled with cancer than ever, more depressed than ever, more suicides than ever, more deaths of despair than ever, your system is not working."
"My goal and our goal at Ways to Well is not to be a dictator and dictate to you take this, do this, do that. No, it's to give you the pros and the cons and to give you the right information to guide you and allow you to take sovereignty and autonomy over your health."
"We are living in the era of X-Men. I can build X-Men today. Like he they have a gene activation shot that can make your bone mineral density eight times stronger."
Q&A
Recent Questions
Related Episodes
Joe Rogan Experience #2469 - Brigham Buhler
"Brigham Buhler reveals how big pharma's lobbying, outdated regulations, and a 'sick care' system stifle innovation in preventative medicine, while cutting-edge therapies like peptides, gene sequencing, and Muse stem cells are poised to revolutionize health, often through cash-pay models and state-level legislative efforts."
They Cut Cancer Research to ZERO (w/ Annabelle Gurwitch) | How to Fix It
"Author Annabelle Gurwitch shares her personal battle with stage 4 lung cancer as a non-smoker, exposing systemic failures in U.S. healthcare, from environmental policy to insurance 'double-dipping' and advocating for European-style cross-state care."
FDA Reverses Decision About Moderna Flu Vaccine
"The FDA made an unprecedented reversal on its refusal to review Moderna's mRNA flu vaccine application, signaling significant political interference and creating regulatory uncertainty for the pharmaceutical industry."
The Poo Doctor: This Cheap Spice Fixes A Damaged Gut!
"Dr. Will Bulsiewicz, a renowned gastroenterologist, reveals how understanding your gut microbiome is the key to resolving chronic inflammation, boosting overall health, and even influencing cancer treatment and neurological conditions."